Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005550 |
---|---|
Receipt number | R000006582 |
Scientific Title | Randomized, open-label, multicenter trial to assess humanized anti-IL-6 receptor antibody, tocilizumab, for the treatment of systemic sclerosis |
Date of disclosure of the study information | 2011/05/23 |
Last modified on | 2017/04/18 18:13:47 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/05/03 15:30:34 | ||
2 | Update | 2012/05/07 13:11:02 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
3 | Update | 2012/11/30 11:20:21 | Recruitment status |
|
4 | Update | 2012/12/03 11:13:29 | Key exclusion criteria |
|
5 | Update | 2013/11/19 19:09:17 | Email |
|
6 | Update | 2016/11/05 21:53:52 | Name of primary person or sponsor Institute Department Organization Organization Category of Funding Organization |
|
7 | Update | 2017/04/18 18:13:47 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Results Results |